SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-134399
Filing Date
2021-11-04
Accepted
2021-11-04 16:18:44
Documents
14
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131564d3_8k.htm   iXBRL 8-K 28906
2 EXHIBIT 99.1 tm2131564d3_ex99-1.htm EX-99.1 75642
6 GRAPHIC tm2131564d3_ex99-1img001.jpg GRAPHIC 2531
  Complete submission text file 0001104659-21-134399.txt   292423

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nxtc-20211104.xsd EX-101.SCH 3189
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nxtc-20211104_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nxtc-20211104_pre.xml EX-101.PRE 22713
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2131564d3_8k_htm.xml XML 3722
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 211380253
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences